BackBeauty Health Company (The) Overview
Beauty Health Company (The) - Ordinary Shares - Class A

Beauty Health Company (The) Return on Equity

Beauty Health Company (The) (SKIN) has a ROE of 240.75%, above the Healthcare sector average of 29.33%.

Get informed when a big investor buys or sells

+ Follow

ROE

240.75%

Return on Equity

240.75%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

Average ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Beauty Health Company (The) (SKIN) FAQ

The latest ROE for SKIN is 240.75%. That is above the Healthcare sector average of 29.33%. Investors often review this figure alongside Beauty Health Company (The)'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, SKIN currently prints 240.75% for ROE, while the sector average sits near 29.33%. That is roughly 720.8% above the sector mean. Large gaps often invite a closer look at Beauty Health Company (The)'s growth, margins, and balance sheet.

Return on Equity shows how effectively Beauty Health Company (The) converts resources into returns. At 240.75%, SKIN may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SKIN's ROE (240.75%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Beauty Health Company (The)'s ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.